1
Home
Companies

Yantai Dongcheng Pharmaceutical

Yantai Dongcheng Pharmaceutical
Leadership team

Ms. Chun Ping Zhu (Financial Director)

Ms. Hong Bo Xin (Deputy GM & Non-Independent Director)

Mr. Zhi Gang Luo (Deputy GM & Non-Independent Director)

Products/ Services
Biotechnology, Chemical Engineering, Health Care, Pharmaceutical
Number of Employees
1,000 - 20,000
Headquarters
Jinan, Shandong, China
Established
1998
Net Income
20M - 100M
Revenue
500M - 1B
Traded as
SZSE:002675
Social Media
URL
https://www.dcb-group.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical API, chemical medicines, proprietary Chinese medicines, and nuclide drugs products in China. It offers heparin, chondroitin sulphate, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C for use in the therapeutic areas of cardiovascular, oncology, urology, orthopedics, and other therapeutic areas. The company also exports its products to approximately 40 countries and regions, including the Europe, America, Asia Pacific, and internationally. Yantai Dongcheng Pharmaceutical Group Co.,Ltd. was founded in 1998 and is based in Yantai, China.
History

Yantai Dongcheng Pharmaceutical Co. was established in 2004 and is located in Yantai City, Shandong Province. It is a high-tech and large-scale modern Chinese medicine and healthcare, product manufacturing enterprise which integrates research, development, production and sales. The transformation and construction of the company is to set healthy physical condition as the base, and to keep the spiritual health of human nature as the goal, is to improve people?s ability of anti-disease and health-care through the combination of TCM characteristic Chinese Medicine Health Care and modern science and technology.

Mission
Our commitment is to fulfill our mission of improving the health, promoting well-being, and providing healthcare solutions to our customers in order to increase people's quality of life and health.
Vision
Our vision is to be the leading Chinese medicine and healthcare company in China, dedicated to providing our customers with the highest quality products and services keeping abreast with the international standards.
Key Team

Ms. Qiong Yi (Deputy Gen. Mang.)

Dr. Zhen Qiu Yang (Deputy Gen. Mang.)

Recognition and Awards
Yantai Dongcheng Pharmaceutical Co., Ltd has been honored with many awards throughout the years, such as being selected by the China Organ Transplantation Development Foundation as the 2012 National Health Training Base, being selected by the China Organ Transplantation Development Foundation as the 2016 National Health Model Company, and winning the 2018 National Today and Tomorrow Pharmaceutical Innovation Award.
References

https://in.investing.com/equities/yantai-dongcheng-pharmaceutical-co

https://finance.yahoo.com/quote/002675.SZ/profile?p=002675.SZ

https://www.crunchbase.com/organization/yantai-dongcheng-pharmaceutical

https://www.dcb-group.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Yantai Dongcheng Pharmaceutical
Leadership team

Ms. Chun Ping Zhu (Financial Director)

Ms. Hong Bo Xin (Deputy GM & Non-Independent Director)

Mr. Zhi Gang Luo (Deputy GM & Non-Independent Director)

Products/ Services
Biotechnology, Chemical Engineering, Health Care, Pharmaceutical
Number of Employees
1,000 - 20,000
Headquarters
Jinan, Shandong, China
Established
1998
Net Income
20M - 100M
Revenue
500M - 1B
Traded as
SZSE:002675
Social Media
URL
https://www.dcb-group.com